Annual Drug Patent Expirations for SLYND
Slynd is a drug marketed by Exeltis Usa Inc and is included in one NDA. It is available from one supplier. There are five patents protecting this drug.
This drug has forty-two patent family members in twenty-seven countries.
The generic ingredient in SLYND is drospirenone. One supplier is listed for this compound. Additional details are available on the drospirenone profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Copyright © DrugPatentWatch. Originally published at New patent for Exeltis Usa drug SLYND